Jacobson Pharma Publicizes FY2025 Annual Outcomes

KEY HIGHLIGHTS- Income up by 7.4% to HK$1,576.9 million- Income from persevering with operations rose by 43.1% to HK$300.8 million- Web gearing ratio correct down to eight.3% from 12.2%- Suggested Last Money Dividend of HK5.50 Cents Per Part and Particular Money Dividend of HK6.00 Cents Per Part- Persevered enrichment of pipeline by R&D and strategic in-licensing- Improved operational effectivity by enhancing ability and optimizing production leverage efficiencyHONG KONG…
Read More